Page 55 - Magyar Gasztroenterológiai Társaság 2020. november 6–7. – ONLINE KONGRESSZUS
P. 55

Előadáskivonatok / Abstracts


                                                              is open for all national centers, which can provide valuable

             Introduction: Small-bowel tumours account for 1 % - 3 % of   is open for all national centers, which can provide val
                                                              data. We plan to extend data collection internationally. uable
             Introduction: Small-bowel tumours account for 1 % - 3 % of
             all  gastrointestinal  neoplasms.  Video  capsule  endoscopy   Results:  Data  collection  will  help  to  determine  factors
                                                              data. We plan to extend data collection internationally.
                                                              Results:  Data  collection  will  help  to  determine  factors
             (VCE) suggests that the frequency of these tumours may be   associated with risk of NASH development and to get closer
             all  gastrointestinal  neoplasms.  Video  capsule  endoscopy
             substantially  higher  than  previously  reported.  The  small   to  the  pathomechanisms  responsible  for  the  liver  fibrosis
             (VCE) suggests that the frequency of these tumours may be
                                                              associated with risk of NASH development and to get closer
             substantially  higher  than  previously  reported.  The  small
             bowel represents 90 % of the overall mucosal surface of the   to  the  pathomechanisms  responsible  for  the  liver  fibrosis
                                                              progression.
             bowel represents 90 % of the overall mucosal surface of the
             alimentary  tract,  it  is  considered  a  rare  location  for  the   progression.
                                                              Conclusions: The objective of this registry is to document
             development  of  neoplasms.  Small-bowel  tumours  grow   the clinical course of NAFLD/NASH disease, to evaluate the
                                                              Conclusions: The objective of this registry is to document
             alimentary  tract,  it  is  considered  a  rare  location  for  the
                                                              the clinical course of NAFLD/NASH disease, to evaluate the
             development  of  neoplasms.  Small-bowel  tumours  grow
             slowly, extraluminally, remaining asymptomatic for years or   effectivity of treatment and to develop a database for clinical
                                                              studies and establish a network for research cooperation in
             slowly, extraluminally, remaining asymptomatic for years or
             presenting insidiously in patients with nonspecific complaints   effectivity of treatment and to develop a database for clinical
             presenting insidiously in patients with nonspecific complaints
                                                              Central and Eastern Europe. ork for research cooperation in
             such as abdominal pain, diarrhoea, iron deficiency anaemia,   studies and establish a netw
             bleeding, extraintestinal symptoms  iron deficiency anaemia,     Central and Eastern Europe.
             such as abdominal pain, diarrhoea,
             Case description: Gy.L. 56 years old male. Medical history:   55.   PRE-TRANSPLANT   SARCOPENIC   OBESITY

             bleeding, extraintestinal symptoms
                                                                                                       LIVER
             Case description: Gy.L. 56 years old male. Medical history:
                                                                   PRE-TRANSPLANT
             LC, T2DM, BPPV, Cataract NAFLD, kidney stones. ACBG   WORSENS   THE   SURVIVAL   AFTER  OBESITY
                                                              55.
                                                                                      SARCOPENIC
                                                                                   A
                                                                                        PROTOCOL
                                                                                                           A
                                                              WORSENS
             surgery,  anticoagulant  therapy  was  initiated.  He  was   TRANSPLANTATION:  SURVIVAL   AFTER   OF  LIVER
             LC, T2DM, BPPV, Cataract NAFLD, kidney stones. ACBG
                                                                           THE
                                                              TRANSPLANTATION:
                                                                                        PROTOCOL
                                                                                                     OF
                                                                                   A
             investigated for anaemia and positive FOBT from 2017. Only   PROSPECTIVE  AND  A  RETROSPECTIVE  COHORT  A
             surgery,  anticoagulant  therapy  was  initiated.  He  was
                                                              STUDY
             investigated for anaemia and positive FOBT from 2017. Only
             diminutive  polyps  found  by  repeated  gastroscopy  and   PROSPECTIVE  AND  A  RETROSPECTIVE  COHORT
                                                              STUDY
             colonoscopy In 2018. he was admitted to our outpatient video   Hegyi P. , Váncsa S. , Hegyi P. 1,2,3 , Pár G.
             diminutive  polyps  found  by  repeated  gastroscopy  and
                                                                               1
                                                                                                3
                                                                    1,3
             capsule  endoscopic  (VCE)  centre.  The  capsule  (Given   1.  Institute  for  Translational  Medicine,  Medical  School,
                                                                     1,3
                                                                                          , Pár G.
                                                                                                3
                                                                               1
                                                                                       1,2,3
             colonoscopy In 2018. he was admitted to our outpatient video
                                                              Hegyi P. , Váncsa S. , Hegyi P.
             capsule  endoscopic  (VCE)  centre.  The  capsule  (Given
                                                              1.  Institute  for  Translational  Medicine,  Medical  School,
             Imaging) cruised with normal peristaltic term into the small-   University  of  Pécs,  Pécs,  Hungary;  2.  First  Department of
             bowel and showed two polyps in the jejuno ileal border and   Medicine,  University  of  Szeged,  Szeged,  Hungary;  3.
                                                              University  of  Pécs,  Pécs,  Hungary;  2.  First  Department of
             Imaging) cruised with normal peristaltic term into the small-
                                                              Medicine,  University  of  Szeged,  Szeged,  Hungary;  3.
             in the proximal part of the ileum. Both of the diameters were   Division of Gastroenterology, First Department of Medicine,
             bowel and showed two polyps in the jejuno ileal border and
             in the proximal part of the ileum. Both of the diameters were
                                                              Division of Gastroenterology, First Department of Medicine,
             8-10 mm. The covering mucosa was damaged and showed.   Medical School, University of Pécs, Pécs, Hungary
             8-10 mm. The covering mucosa was damaged and showed.
             oozing  of  blood.  Surgical  resection  was  done.  Histology     Medical School, University of Pécs, Pécs, Hungary

                                      gastric
                                              metaplasia.
                                 with
                                                         No
                     hamartomas
             oozing
             verified of  blood.  Surgical  resection  was  done.  Histology   Introduction: Non-alcoholic fatty liver disease became the
                     hamartomas
             complications were found, the patient recovered. The was no   second  leading  aetiology  of  liver  disease  among  adults
                                                              Introduction: Non-alcoholic fatty liver disease became the
                                              metaplasia.
                                                         No
             verified
                                       gastric
                                 with
                                                              second  leading  aetiology  of  liver  disease  among  adults
             recurrence of anaemia or positive FOBT during follow up.    awaiting  liver  transplantation  (LT)  and  it  is  predicted  to
             complications were found, the patient recovered. The was no
             Conclusion: VCE is an accurate, safe, and painless method   become the leading indication for LT by 2030. These patients
             recurrence of anaemia or positive FOBT during follow up.
                                                              awaiting  liver  transplantation  (LT)  and  it  is  predicted  to
             of endoscopically evaluating all of the small bowels. The VCE   often develop obesity and sarcopenia simultaneously, coined
             Conclusion: VCE is an accurate, safe, and painless method
                                                              become the leading indication for LT by 2030. These patients
             is the authentical method of evaluating the origin of occult   often develop obesity and sarcopenia simultaneously, coined
                                                              as sarcopenic obesity (SO).
             of endoscopically evaluating all of the small bowels. The VCE
             is the authentical method of evaluating the origin of occult
             gastrointestinal  bleeding  even  caused  rare small  intestinal   Aim: Our study aims to investigate whether the incorporation
                                                              as sarcopenic obesity (SO).
             tumours.                                         Aim: Our study aims to investigate whether the incorporation
                                                              of  pre-transplant  body  composition  into  prognostic  scores
             gastrointestinal  bleeding  even  caused  rare small  intestinal
               tumours.                                       of  pre-transplant  body  composition  into  prognostic  scores
                                                              results in a formula with high predictive accuracy for post-
             54.  NON-ALCOHOLIC  FATTY  LIVER  DISEASE/  NON-  transplant outcomes.  with high predictive accuracy for post-
                                                              results in a formula

             ALCOHOLIC STEATOHEPATITIS DISEASE REGISTRY IN    Methods:  The  cohort  study  consists  of  retrospective  and
             54.  NON-ALCOHOLIC  FATTY  LIVER  DISEASE/  NON-
                                                              transplant outcomes.
                                                              prospective parts, planned and carried out by the Hungarian
             ALCOHOLIC STEATOHEPATITIS DISEASE REGISTRY IN
             HUNGARY: A PROTOCOL                              Methods:  The  cohort  study  consists  of  retrospective  and
                               1
                    1,2
                                        3
             HUNGARY: A PROTOCOL
                                                          4
             Hegyi  P. ,  Váncsa  S. ,  Papp  M. ,  Janka  T. ,  Gajdán  L. ,   Liver Study Group of the Centre for Translational Medicine at
                                                3
                                                              prospective parts, planned and carried out by the Hungarian
                            2
                      , Pár G.
                                                              University of Pecs. Liver transplantation centres from Central
                    1,2,5
             Hegyi P. P. ,  Váncsa  S. ,  Papp  M. ,  Janka  T. ,  Gajdán  L. ,   Liver Study Group of the Centre for Translational Medicine at
             Hegyi
                                                 3
                                                          4
                    1,2
                                        3
                               1
                                                              and  Eastern  European  countries  will  be  asked  to  join  the
                    1,2,5
                      , Pár G.
             Hegyi P.
             1.  Institute  for  Translational  Medicine,  Medical  School,   University of Pecs. Liver transplantation centres from Central
                            2
             1.  Institute  for  Translational  Medicine,  Medical  School,
             Szentágothai  Research  Centre,  University  of  Pécs,  Pécs,   project. In the retrospective cohort study, pre-defined forms
                                                              and  Eastern  European  countries  will  be  asked  to  join  the
                                                              project. In the retrospective cohort study, pre-defined forms
             Hungary;  2.  Department  of  Gastroenterology,  Medical   will  be  used  to  collect  data  on  medical  history,  physical
             Szentágothai  Research  Centre,  University  of  Pécs,  Pécs,
             School,  University  of  Pécs,  Pécs,  Hungary;  3.  Second   status,  signs  and  laboratory  tests.  Retrospectively
                                                              will  be  used  to  collect  data  on  medical  history,  physical
             Hungary;  2.  Department  of  Gastroenterology,  Medical
             Department  of  Internal  Medicine,  University  of  Debrecen,   sarcopenia, obesity, and SO will be assessed with a special
             School,  University  of  Pécs,  Pécs,  Hungary;  3.  Second
                                                              status,  signs  and  laboratory  tests.  Retrospectively
             Debrecen, Hungary; 4. Szent György Teaching Hospital of   software dedicated to estimating body composition based on
             Department  of  Internal  Medicine,  University  of  Debrecen,
                                                              sarcopenia, obesity, and SO will be assessed with a special
             Debrecen, Hungary; 4. Szent György Teaching Hospital of
             County Fejér, Székesfehérvár, Hungary; 5. First Department   CT scans of the patients who were on waiting list for LT. The
                                                              software dedicated to estimating body composition based on
             County Fejér, Székesfehérvár, Hungary; 5. First Department
                                                              primary outcome will be post-LT survival. In the prospective
             of Medicine, University of Szeged, Szeged, Hungary   CT scans of the patients who were on waiting list for LT. The
                                                              cohort study, patients will be enrolled when signed up for the
               of Medicine, University of Szeged, Szeged, Hungary   primary outcome will be post-LT survival. In the prospective

             Introduction: Non-alcoholic fatty liver disease (NAFLD) is   cohort study, patients will be enrolled when signed up for the
                                                              waiting list of LT and data collection and measurements will
             Introduction: Non-alcoholic fatty liver disease (NAFLD)
             now recognized as the most prevalent chronic liver disease  is   waiting list of LT and data collection and measurements will
                                                              be carried out prospectively; data will be recorded in a patient
             worldwide. About 15% of the NAFLD cases progress to non-   registry. d out prospectively; data will be recorded in a patient
                                                              be carrie
             now recognized as the most prevalent chronic liver disease
             alcoholic steatohepatitis (NASH), which increases the risk of      registry.
             worldwide. About 15% of the NAFLD cases progress to non-

             progressive fibrosis to cirrhosis and end-stage liver disease.    Conclusions: Abnormal body composition has a substantial
             alcoholic steatohepatitis (NASH), which increases the risk of
             progressive fibrosis to cirrhosis and end-stage liver disease.
             Purpose: The registry aims to clarify the prevalence, the risk   negative  impact  on  post-LT  survival.  Since  a  CT  scan  is
                                                              Conclusions: Abnormal body composition has a substantial
                                                              negative  impact  on  post-LT  survival.  Since  a  CT  scan
             factors, and the outcomes of NAFLD/NASH.         mandatory before LT, data are easily available to estimate  is
             Purpose: The registry aims to clarify the prevalence, the risk
             factors, and the outcomes of NAFLD/NASH.
             Methods: The registry for NAFLD/NASH diseases received   mandatory before LT, data are easily available to estimate
                                                              body  composition  and  the  opportunity  is  given  to  arrange
                                                              countermeasures.  and  the  opportunity  is  given  to  arrange
             ethical  and  biobank  permission  in  2019  (TUKEB-59061-   body  composition
             Methods: The registry for NAFLD/NASH diseases received
             ethical  and  biobank  permission  in  2019  (TUKEB-59061-
             5/2016/EKU). This multicenter, prospective, national registry     countermeasures.
             5/2016/EKU). This multicenter, prospective, national registry
             will initially involve three centers in Hungary. Participation is   56.   PRE-TRANSPLANT   SARCOPENIC   OBESITY

                                                                                      SARCOPENIC
                                                                                                       LIVER
             will initially involve three centers in Hungary. Participation is
                                                                   PRE-TRANSPLANT
                                                              56.
             voluntary  and  based  on  written  consent.  Any  patient   WORSENS   THE   SURVIVAL   AFTER  OBESITY
                                                                                              AFTER
                                                                           THE
                                                              WORSENS
                                                                                 SURVIVAL
             diagnosed with NAFLD/NASH disease will be included upon   TRANSPLANTATION:  A  META-ANALYSIS  AND  A
                                                                                                       LIVER
             voluntary  and  based  on  written  consent.  Any  patient
                                                              SYSTEMATIC REVIEW  A  META-ANALYSIS  AND  A
             diagnosed with NAFLD/NASH disease will be included upon
             gastroenterological  presentation.  Details  from  medical   TRANSPLANTATION:
                                                                     1,3
             history,  status,  complaints,  laboratory  and  imaging   SYSTEMATIC REVIEW   1,2,3 , Szakács Z. , Hanák L. ,
                                                                             3
                                                              Hegyi P. , Soós A. , Hegyi P.
                                                                                                           3
                                                                                                  3
             gastroenterological  presentation.  Details  from  medical
                                                                              3
             history,  status,  complaints,  laboratory  and  imaging
                                                                                                 1 3
                                                                                         1,3
             examination, and therapy will be prospectively collected on   Hegyi P. , Soós A. , Hegyi P. 1,2,3 , Szakács Z.  3
                                                                                 3
                                                                       3
                                                                     1,3
                                                              Pétervári E. , Balaskó M. , Erőss B. , Pár G.   , Hanák L. ,
                                                   when
             enrollment.   Blood   sampling   is pectively collected on   Pétervári E. , Balaskó M. , Erőss B. , Pár G.
                                                                                 3
                                                                                         1,3
                                                              1.  Division  of  Gastroenterology,  First  Department  of
                                                                                                 1
                                             done
                                                                       3
             examination, and therapy will be pros
                                                          a
                                             done
             enrollment.
                                                              Medicine,  Medical  School,  University  of  Pécs,  Pécs,
                                         is
                                sampling
                                                    when
             gastroenterologist  orders  laboratory  examination;  no  a   1.  Division  of  Gastroenterology,  First  Department  of
                         Blood
             additional intervention will be needed. Follow-up is planned   Hungary; 2. Clinical Medicine Doctoral School, University of
                                                              Medicine,  Medical  School,  University  of  Pécs,  Pécs,
             gastroenterologist  orders  laboratory  examination;  no
             for every participant at 6 and 12 months and then yearly to 5   Szeged,  Szeged,  Hungary;  3.  Institute  for  Translational
             additional intervention will be needed. Follow-up is planned
                                                              Hungary; 2. Clinical Medicine Doctoral School, University of
             years, with the same structure as on enrollment. The registry   Szeged,  Szeged,  Hungary;  3.  Institute  for  Translational
             for every participant at 6 and 12 months and then yearly to 5
             years, with the same structure as on enrollment. The registry
                                                                                                          53
                                                                                                          53

                                                                Central European Journal of Gastroenterology and Hepatology   53
                                                                            Volume 6, Supplementum 2 / November 2020
   50   51   52   53   54   55   56   57   58   59   60